617 related articles for article (PubMed ID: 22245962)
21. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
[TBL] [Abstract][Full Text] [Related]
22. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
23. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
Chinnadurai R; Ritchie J; Green D; Kalra PA
Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
[TBL] [Abstract][Full Text] [Related]
24. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease in lean individuals in the United States.
Younossi ZM; Stepanova M; Negro F; Hallaji S; Younossi Y; Lam B; Srishord M
Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
[TBL] [Abstract][Full Text] [Related]
27. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.
Ruhl CE; Everhart JE
Am J Gastroenterol; 2013 Jun; 108(6):952-8. PubMed ID: 23545713
[TBL] [Abstract][Full Text] [Related]
28. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
29. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.
Riquelme A; Arrese M; Soza A; Morales A; Baudrand R; Pérez-Ayuso RM; González R; Alvarez M; Hernández V; García-Zattera MJ; Otarola F; Medina B; Rigotti A; Miquel JF; Marshall G; Nervi F
Liver Int; 2009 Jan; 29(1):82-8. PubMed ID: 18647235
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
Luo J; Xu L; Li J; Zhao S
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
[TBL] [Abstract][Full Text] [Related]
32. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
Rahimi RS; Landaverde C
Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
[TBL] [Abstract][Full Text] [Related]
33. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
34. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
[TBL] [Abstract][Full Text] [Related]
35. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
Picardi A; Vespasiani-Gentilucci U
Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
[TBL] [Abstract][Full Text] [Related]
36. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals.
Kim BJ; Kim NH; Kim BS; Kang JH
Cardiology; 2012; 123(1):54-61. PubMed ID: 22986520
[TBL] [Abstract][Full Text] [Related]
37. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.
Ghouri N; Preiss D; Sattar N
Hepatology; 2010 Sep; 52(3):1156-61. PubMed ID: 20658466
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes.
Boddi M; Tarquini R; Chiostri M; Marra F; Valente S; Giglioli C; Gensini GF; Abbate R
Eur J Clin Invest; 2013 May; 43(5):429-38. PubMed ID: 23480577
[TBL] [Abstract][Full Text] [Related]
39. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]